Indication
Mitochondrial Disease
2 clinical trials
2 products
Product
VatiquinoneClinical trial
An Open-Label, Safety Study for Previously Treated Vatiquinone (PTC743) Subjects With Inherited Mitochondrial DiseaseStatus: , Estimated PCD: 2025-03-31
Clinical trial
A Multiple Ascending Phase 1 Dose Study of N-acetylcysteine in the Treatment of Patients With the m.3243A>G Mutation and Low Brain Glutathione LevelsStatus: Recruiting, Estimated PCD: 2024-06-01
Product
N-Acetylcysteine